View Rule

This proposed rule, if finalized, would allow importation of certain prescription drugs from Canada under certain circumstances. States and certain other non-federal governmental entities would be able to submit importation program proposals to FDA for review and authorization. An importation program could be co-sponsored by a pharmacist, a wholesaler, or another State or non-federal governmental entity. The rule, when finalized, would contain requirements to demonstrate that an importation program will pose no additional risk to the public’s health and safety and would be expected to result in a significant reduction in the cost of covered products to the American consumer.